THE SARCOMA JOURNAL—OFFICIAL JOURNAL OF THE SARCOMA FOUNDATION OF AMERICA™

Home » Brands Posts » THE SARCOMA JOURNAL—OFFICIAL JOURNAL OF THE SARCOMA FOUNDATION OF AMERICA™

The Sarcoma Journal—Official Journal of the Sarcoma Foundation of America (SFA), www.curesarcoma.org, a leading sarcoma patient advocacy organization, is a conduit to inform and educate physicians and allied healthcare professionals (HCPs) on the latest research and leading treatments for soft/connective-tissue tumors. Published seasonally by MDedge™ Hematology & Oncology, The Sarcoma Journal—Official Journal of the Sarcoma Foundation of America (www.mdedge.com/sarcomajournal, part of the MDedge™ web portal) addresses the needs of oncologists, pediatric oncologists and other HCPs treating sarcomas by providing professional resources covering the most current medical news, diagnosis and treatment information on these cancer types. The journal supports SFA’s activities focused on funding research, increasing awareness, and providing information on clinical trials throughout the U.S. By facilitating communication among the medical and scientific community, The Sarcoma Journal—Official Journal of the Sarcoma Foundation of America seeks to support early detection, patient education, and more rapid developments of new and better sarcoma treatments, as part of the continuum of care.

Our offerings

Extend Your Reach

Frontline Medical Communications provides unique and unparalleled digital solutions around our trusted brands. Reach your target audience broadly through The Sarcoma Journal – Official Journal of the Sarcoma Foundation of America™ mobile-optimized website, updated daily, and broadcast emails. Or, segment your message and narrow your reach through our unique, validated HCP eDatabase; MD-IQ™ interactive self-assessment clinical challenges; ClinicalEdge® summaries from the literature; or a disease-state HUB built from our credible, authoritative content. Check all of your opportunities in our media kit available here or get in touch with our Key Contacts.

Focus on
Rates
Key Contacts